Market is just not taking BIT seriously, and can you blame it. However, the potential upside from here is massive with the antiviral and HIV results due soon. Its certainly worth a lot more than the MC of 26 mill, even with the current management. All IMO
- Forums
- ASX - By Stock
- BIT
- Ann: Commencement Phase 2 Covid-19 Clinical Trial
Ann: Commencement Phase 2 Covid-19 Clinical Trial, page-26
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
3.5¢ |
Change
0.002(6.06%) |
Mkt cap ! $31.57M |
Open | High | Low | Value | Volume |
3.3¢ | 3.5¢ | 3.3¢ | $19.27K | 566.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 299989 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 371664 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 299989 | 0.034 |
3 | 240016 | 0.033 |
2 | 242406 | 0.032 |
6 | 600480 | 0.031 |
9 | 670666 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 371664 | 3 |
0.036 | 65500 | 1 |
0.037 | 767816 | 3 |
0.039 | 430546 | 2 |
0.040 | 113240 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online